Antibodies to common infectious agents in coronary artery disease patients with and without rheumatic conditions

Rheumatology

Volumn 51, Issue 4, 2012, Pages 679-685

  Grub, Carola ^a   Brunborg, Cathrine ^b   Hasseltvedt, Viggo ^a   Aukrust, Pål ^c   Førre, Øystein ^c   Almdahl, Sven Martin ^d   Hollan, Ivana ^d,e  

^a INNLANDET HOSPITAL TRUST   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d Feiring Heart Clinic AS   (Norway)

^e Hospital for Rheumatic Diseases   (Norway)

Author keywords

Antibodies; Coronary artery disease; Infection; Inflammatory rheumatic disease

Indexed keywords

ANTIBODY; CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN A;

ADVENTITIA; AGED; ANTIBODY PRODUCTION; ARTICLE; ATHEROSCLEROSIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS; FEMALE; HELICOBACTER PYLORI; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN PARVOVIRUS B19; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIAE; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATIC DISEASE; RISK FACTOR; STREPTOCOCCUS PYOGENES; VASCULITIS;

AGED; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; AORTA; BACTERIAL INFECTIONS; CASE-CONTROL STUDIES; CONNECTIVE TISSUE; CORONARY ARTERY DISEASE; FEMALE; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; PNEUMONIA, MYCOPLASMA; RHEUMATIC DISEASES; VIRUS DISEASES;

EID: 84858639522     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker251     Document Type: Article

References (33)

1. Sarzi-Puttini P, Atzeni F, Gerli R et al. Cardiac involvement in systemic rheumatic diseases: an update. Autoimmun Rev 2010;9:849-52.
2. Madjid M, Vela D, Khalili-Tabrizi H, Casscells SW, Litovsky S. Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes. Tex Heart Inst J 2007;34:11-8.
3. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26.
4. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
5. Pasceri V, Yeh ET. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 1999;100:2124-6.
6. Mayr M, Kiechl S, Willeit J, Wick G, Xu Q. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 2000;102:833-9.
7. Rahel BM, Visseren FL, Suttorp MJ et al. Cytomegalovirus and chlamydia pneumoniae as predictors for adverse events and angina pectoris after percutaneous coronary intervention. Am Heart J 2004;148:670-5.
8. Momiyama Y, Ohmori R, Taniguchi H, Nakamura H, Ohsuzu F. Association of Mycoplasma pneumoniae infection with coronary artery disease and its interaction with chlamydial infection. Atherosclerosis 2004;176: 139-44.
9. Liu SC, Tsai CT, Wu CK et al. Human parvovirus B19 infection in patients with coronary atherosclerosis. Arch Med Res 2009;40:612-7.
10. Valtonen JM, Koskimies S, Miettinen A, Valtonen VV. Various rheumatic syndromes in adult patients associated with high antistreptolysin O titres and their differential diagnosis with rheumatic fever. Ann Rheum Dis 1993;52: 527-30.
11. Chen YS, Chou PH, Li SN et al. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan. J Rheumatol 2006;33:887-91.
12. Vassilopoulos D, Calabrese LH. Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations. Arthritis Res Ther 2008;10:215.
13. Huang Q, Pope RM. Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis. J Leukoc Biol 2010;88:253-62.
14. Drexler SK, Foxwell BM. The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol 2010;42: 506-18.
15. Hollan I, Prayson R, Saatvedt K et al. Inflammatory cell infiltrates in vessels with different susceptibility to atherosclerosis in rheumatic and non-rheumatic patients: a controlled study of biopsy specimens obtained at coronary artery surgery. Circ J 2008;72: 1986-92.
16. Hollan I, Scott H, Saatvedt K. et al. Inflammatory rheumatic disease and smoking are predictors of aortic inflammation: a controlled study of biopsy specimens obtained at coronary artery surgery. Arthritis Rheum 2007;56: 2072-9.
17. Kirkwood BR, Sterne JAC. Medical statistics. Oxford: Blackwell Science Ltd, 2003.
18. Veenendaal RA, Biemond I, Pena AS, van DW, Kreuning J, Lamers CB. Influence of age and Helicobacter pylori infection on serum pepsinogens in healthy blood transfusion donors. Gut 1992;33:452-5.
19. Anderson LJ, Tsou C, Parker RA et al. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol 1986;24:522-6.
20. Frosner GG, Peterson DA, Holmes AW, Deinhardt F. [Presence of hepatitis B antibody in operators of a plasma fractionating plant, hospital staff, patients, and blood donors]. Zentralbl Bakteriol Orig A 1974;227:363-7.
21. Paldanius M, Bloigu A, Alho M, Leinonen M, Saikku P. Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland. Clin Diagn Lab Immunol 2005;12:654-9.
22. Cheng J, Ke Q, Jin Z et al. Cytomegalovirus infection causes an increase of arterial blood pressure. PLoS Pathog 2009;5:e1000427.
23. Grahame-Clarke C, Chan NN, Andrew D et al. Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation 2003;108: 678-83.
24. Simmonds J, Fenton M, Dewar C et al. Endothelial dysfunction and cytomegalovirus replication in pediatric heart transplantation. Circulation 2008;117:2657-61.
25. Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 1997;96: 2144-8.
26. Johnson SM, Bruckner F, Collins D. Distribution of Mycoplasma pneumoniae and Mycoplasma salivarium in the synovial fluid of arthritis patients. J Clin Microbiol 2007;45:953-57.
27. Lundqvist A, Isa A, Tolfvenstam T, Kvist G, Broliden K. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients. J Clin Virol 2005;33: 71-4.
28. Goyal R, Bulua AC, Nikolov NP, Schwartzberg PL, Siegel RM. Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders. Curr Opin Rheumatol 2009;21:78-84.
29. Salinas-Carmona MC, Perez LI, Galan K, Vazquez AV. Immunosuppressive drugs have different effect on B lymphocyte subsets and IgM antibody production in immunized BALB/c mice. Autoimmunity 2009;42:537-44.
30. Trollmo C, Gudmundsson S, Feltelius N, Rogberg S, Smedegård G, Klareskog L. Sulphasalazine inhibits human antigen-specific immune responses in vivo. Ann Rheum Dis 2007;66:481-5.
31. Pinschewer DD, Ochsenbein AF, Fehr T, Zinkernagel RM. Leflunomide-mediated suppression of antiviral antibody and Tcell responses: differential restoration by uridine. Transplantation 2001;72:712-9.
32. Thewissen M, Somers V, Venken K et al. Analyses of immunosenescent markers in patients with autoimmune disease. Clin Immunol 2007;123:209-18.
33. Paldanius M, Leinonen M, Virkkunen H et al. Chlamydia pneumoniae antibody levels before coronary events in the Helsinki Heart Study as measured by different methods. Diagn Microbiol Infect Dis 2006;56: 233-9.